Transforming growth factor-h (TGF-h) has been identified as a key mediator of glomerulosclerosis in kidney diseases. Endoglin is a component of the TGF-h receptor system that is upregulated during glomerulosclerosis, suggesting a role during progression of renal diseases characterized by extracellular matrix (ECM) synthesis and accumulation. The expression of endoglin was demonstrated in cultured human mesangial cells (HMC) by flow cytometry, Northern blot, reverse transcriptase polymerase chain reaction (RT-PCR), and Western blot analyses. TGF-h upregulated not only the expression of endoglin, but also that of TGF-h itself, TGF-h receptor type II, collagen I, collagen IV, and fibronectin. To study the role of endoglin in TGF-h responses, transfectant fibroblasts overexpressing endoglin were analyzed. Untreated and TGF-h-treated endoglin + cells showed significantly lower levels of collagens than those in control cells, indicating that endoglin negatively regulates ECM levels of collagens. These findings may have important implications in the pathological states associated with renal fibrosis. D
Introduction
The molecular basis responsible for the progression of kidney diseases to end-stage renal failure remains still obscure. Glomerular and tubulointerstitial fibrosis characterized by excessive accumulation of extracellular matrix (ECM) appears to occur independently of the primary underlying disorder. The ability of glomerular mesangial cells (GCM) to modulate their proliferative phenotype and secrete ECM supports their crucial role in the development and progression of the glomerular disorder [1] . These aspects of GCM behavior can be modified by transforming growth factor beta 1 (TGF-h1), a multifunctional cytokine that modulates proliferation, morphogenesis, development, injury, and repair [2, 3] . Thus, TGF-h has been identified as a key mediator of glomerulosclerosis in both experimental animal models and human kidney diseases [4, 5] . In various cell types, TGF-h promotes the transcription, synthesis and secretion of numerous proteins of the ECM including collagens, fibronectin, and proteoglycans [6, 7] . It also decreases the degradation of ECM molecules by downregulating ECM-degrading proteases, stimulating synthesis of protease inhibitors and increasing transcription and expression of integrins that are receptors for ECM molecules [6, 8] . The ECM provides a structural basis for multicellularity, whereas growth factors facilitate the transfer of information required for construction of the complex cellular network. In this sense, some authors postulate that ECM plays a major role in the control of growth factor signaling [9] , and immunohistochemical studies have suggested that TGF-h associates with interstitial ECM and basement membranes [10] .
Members of the TGF-h superfamily exert their function through binding to specific receptors, including receptors type I (R-I), type II (R-II), betaglycan, and endoglin [11] . Among these, the serine-threonine kinase receptors type I and II are necessary for all tested biological responses to TGF-h [12, 13] . Thus, TGF-h binding to the constitutively phosphorylated R-II is followed by recruitment of R-I into the complex, phosphorylation of R-I, and propagation of the signal to downstream substrates of the Smad family of proteins [14] .
Endoglin is a 180-kDa homodimeric membrane glycoprotein expressed by human endothelial cells [15] , macrophages [16] , stromal cells [17, 18] , and vascular smooth muscle cells [19 -21] . The gene encoding endoglin has been identified as the target gene for the autosomal dominant vascular disorder known as Hereditary Hemorrhagic Telangiectasia type 1 [22] . Endoglin binds at least TGF-h1, TGF-h3, activin, BMP-2, and BMP-7 [23, 24] . Two different isoforms, L-endoglin and S-endoglin, with the capacity to bind TGF-h but differing in the amino acid composition of their cytoplasmic tails, have been characterized [25, 26] . As endoglin is able to modulate cellular responses to TGF-h [27 -29] , the presence of endoglin in different TGF-h-modulated cell types suggests its possible regulatory ability. Among resident renal cells, mesangial cells are well-defined targets for TGF-h and play a central role in the development of glomerular sclerosis. The possible role for endoglin in the genesis of this process has been poorly evaluated. In the present study, we have investigated the expression of endoglin mRNA and protein in human mesangial cells (HMC), as well as its possible role in the dynamic equilibrium of synthesis and degradation of ECM. We propose that the expression of endoglin may have a role in regulating the effects of TGF-h in HMC.
Materials and methods

Cell culture
HMC were cultured according to previously described procedures [30] , with minor modifications. Portions of macroscopically normal cortical tissue were obtained from human kidney immediately after nephrectomy. The cortex was cut into slices and washed twice to remove contaminating blood. The material was successively pushed through 180-and 105-Am stainless steel sieves and washed to obtain isolated glomeruli free of tubular contamination. Hank's Balanced Salt Solution (HBSS) was used in all steps of the glomerular isolation procedure. Glomeruli were then treated with collagenase (Sigma Chemicals, St. Louis, MO), plated in plastic culture dishes, and maintained in RPMI 1640 supplemented with 10% fetal calf serum (FCS), 1 mM Lglutamine, 100 units/ml penicillin, and 60 Ag/ml streptomycin sulfate. Cells were buffered with HEPES and bicarbonate, pH 7.4, and grown in a 5% CO 2 atmosphere. Culture media were changed every 2 days. When cells reached confluency, they were subcultured at a ratio of 1:4 using the same incubation medium. The experiments were performed in passages 10-12. The identity of HMC was confirmed by morphological and functional criteria as previously described [31] . Additional studies were performed in cells cultured on two-dimensional type I or IV collagen films [32] . For this purpose, Petri dishes were treated for 16 h with a solution containing 12.5 Ag/ml collagen I or collagen IV (Sigma) in bicarbonate buffer (15 mM Na 2 CO 3 , 35 mM NaHCO 3 , pH 9), washed with HBSS to restore the pH 7.5, and seeded with trypsinized cells. After 48 h, cells were serumdeprived for 24 h, and total RNA extracted. For TGF-h treatments, HMC were serum-deprived for 24 h, followed by incubation in serum-free medium containing 1 -10 ng/ml TGF-h1 (R&D Systems) for an additional period of 24 h, as indicated.
Human umbilical vein endothelial cells (HUVEC) were isolated from cannulated vessels incubated in the presence of collagenase for 20 min at 37 jC. Detached cells were plated in gelatin-coated flasks and grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% heat inactivated FCS.
The mouse fibroblast cell line L929 was cultured in DMEM supplemented with 10% heat-inactivated FCS, 2 mM L-glutamine, and 100 units/ml penicillin in a 5% CO 2 atmosphere at 37 jC. The generation of L929 fibroblast transfectants expressing human endoglin has been previously described [26] . Mock and endoglin-transfected (endoglin + ) fibroblasts were grown with complete DMEM medium in the presence of 400 Ag/ml of the antibiotic G418. For TGF-h treatments, cells were plated in 60-mm culture dishes at 4 Â 10 5 cells/dish. Twenty four hours later, cells were serum-starved for 24 h prior incubation with 1 or 10 ng/ml TGF-h1 in serum-free medium for 24 -48 h. Collagen synthesis was quantified by measuring the incorporation of [ 3 H]-proline to collagen proteins, as described elsewhere [33] . a 2 (I) collagen mRNA levels were measured by Northern blot as described below.
Analysis of endoglin mRNA expression by reverse transcriptase polymerase chain reaction (RT-PCR)
Endoglin mRNA expression in cultured HMC was measured by using the RT-PCR assay. In every case, total RNA was extracted from cells, according to the method of Chomczynsky and Sacchi [34] , and both the quantity and the quality of the RNA were verified by ethidium bromidestaining of mRNA bands on an agarose minigel.
The amplification of L-endoglin was achieved using E#11R primer 5V-CTGGGTCGAGTGGAGGACTG-3V and E#12R primer 5V-CAAGACCGGGTCTCAAGACC-3V. Two micrograms of total RNA was reverse-transcribed by incubating at 42 jC for 30 min (RNA PCR kit; Roche Molecular Biochemicals). For polymerase chain reaction (PCR), the cDNA obtained after the RT reaction was amplified with the L-endoglin primers and combined with 0.2 mM of each deoxynucleotide triphosphate in 100 Al solution that contained 1 Â PCR buffer, 2 mM MgCl 2 , and 2.5 U of Taq DNA polymerase. PCR was programmed for 1 cycle at 95 jC 5 min, 35 cycles at 95, 55, 72 jC of 1 min 30 s, respectively, and 1 cycle at 72 jC 10 min. The amplified cDNAs were electrophoresed through a 1.5% agarose gel. PCR amplification yielded a single band corresponding to a 414-bp cDNA fragment whose sequence analysis confirmed its identity with human L-endoglin [26] . Contamination was ruled out by a negative PCR when the reverse-transcription step was omitted.
Analysis of mRNA expressions by Northern blot
HMC or mouse fibroblasts were homogenized using guanidinium isothiocyanate, and total RNA was isolated by repeated phenol -chloroform extractions and isopropanol precipitation as described [34] . Total RNA (10 Ag per lane) was denatured by heating in formamide/formaldehyde at 100 jC for 3 min and electrophoresed through a 1% agarose gel containing 0.66 M formaldehyde. The RNA was transferred to nitrocellulose membrane (Amersham Biosciences) by capillary blotting and ultraviolet hybridizations were performed in a rotating drum in a temperature-controlled oven.
The membranes were prehybridized at 42 jC for 24 h in 5 Â SSPE (20 
Ficoll, 1% polyvinylpyrrolidone, 1% bovine serum albumin, 50% formamide, 0.1% SDS), and 0.1 mg/ml denatured salmon sperm DNA. cDNA inserts were radiolabeled with 5 ACi a 32 P-dCTP (3000 Ci/mmol; Amersham Biosciences) using a radiolabeling system (Rediprime; Amersham Biosciences). Mouse a 1 (IV) collagen probe was kindly provided by Dr. Kurkinen (Detroit, MI). The cDNA probes encoding mouse TGF-h 1 , fibronectin, and rat a 2 (I) collagen were gifts from Dr. Ziyadeh (Philadelphia, PA), and human L-endoglin probe was synthesized by the PCR using human kidney as described above. Blots were hybridized for 24 h with 10 6 cpm/ml probe at 42 jC in the same buffer used for prehybridization. Then, membranes were washed twice for 5 min each in 2 Â SSC (20 Â SSC: 3 M NaCl, 0.3 M sodium citrate, pH 7.0) and 0.5% SDS at 42 jC and then for 5 min in 1 Â SSC, 0.5% SDS at 42 jC. Autoradiography was performed with intensifying screens (X-OMAT, Kodak) at À 80 jC for 24 -48 h. Blots were stripped for 30 min in 0.1% SDS, 0.1 Â SSC at 100 jC and re-hybridized with the remaining probes listed. Densitometric analysis of the exposed films was performed with an Apple scanner and appropriate software (NIH Image 1.55 from the National Institutes of Health).
Flow cytometry
HMC were incubated with either a rabbit polyclonal antibody to human endoglin [35] at 1:1000 dilution, or with the mouse monoclonal antibody W6/32 against the human major histocompatibility antigen type I (Sigma) for 30 min at 4 jC. After two washes with PBS, FITC-labeled F(abV)2 rabbit anti-mouse Ig or swine anti-rabbit Ig (Dakopatts) was added and incubation proceeded for an additional period of 30 min at 4 jC. Finally, cells were washed twice with PBS and their fluorescence was estimated with an EPICS-CS (Coulter Cientifica, Mostoles, Spain), using logarithmic amplifiers. Nonspecific rabbit and mouse immunoglobulins were also used as negative controls.
Western blot analysis
HMC or rat myoblast stable transfectants expressing human L-endoglin [28] , were cultured to 70-80% confluency, trypsinized, collected by centrifugation, and solubilized in lysis buffer (10 mM Tris -HCl pH 7.4, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, 10 Ag/ml pepstatin, 50 Ag/ml leupeptin, 1 mM benzamidine and 1 mM phenylmethylsulfonyl fluoride), for 40 min al 4 jC. Total extracts (30 -60 Ag/lane) were subjected to SDS-PAGE on 7.5% polyacrylamide gels under either reducing or nonreducing conditions. Proteins were electrophoretically transferred to nitrocellulose membranes (Millipore Corp., Bedford, MA, USA). Filters were blocked with PBS containing 5% milk powder for 1 h. Specific immunodetection was carried out by incubation with a rabbit polyclonal antibody to human endoglin [35] , or the corresponding pre-immune antibody, followed by peroxidase-conjugated goat anti-rabbit Ig at room temperature. The presence of endoglin was detected using a chemiluminescence assay (ECL detection kit; Amersham Biosciences).
Statistical analysis
Results shown are the mean F S.E., and n = number of experiments (see figure legends). The Northern blot densitometry data were corrected for variations in gel loading by accounting for the relative intensities of the 18 S band or glyceraldehyde-3-phosphate dehydrogenase (GAPDH). When n < 10, nonparametric statistics were used for comparisons (Friedman's and Wilcoxon's tests). A P < 0.05 was considered statistically significant.
Results
Expression of endoglin in HMC
Mesangial cells obtained from human kidney after nephrectomy were analyzed for endoglin expression. As shown in Fig. 1A , endoglin transcripts were detected by RT-PCR in quiescent cultured HMC. Using specific primers to human endoglin, a single 416-bp PCR product of the predicted size corresponding to the L-endoglin isoform was obtained. To confirm that this band represented endoglin, it was purified, cloned into pCR-Script SK(+) plasmid, and sequenced. Moreover, endoglin was expressed on the surface of the HMC (Fig. 1B) . The analysis by flow cytometry using a rabbit polyclonal antibody to human endoglin demonstrated the expression of the protein on the cell membrane, suggest-ing a possible functional role in the TGF-h receptor system. The presence of endoglin in HMC was further confirmed by Western blot under reducing (R) or nonreducing (NR) conditions, indicating that HMC endoglin naturally appears in a dimeric form (Fig. 1C ).
TGF-h1 regulates the expression of endoglin, R-II and TGF-h
TGF-h is known to regulate its own expression, as well as that of TGF-h receptor components, including endoglin Samples of total RNA from HMC or HUVEC were incubated either in the presence (+) or in the absence ( À ) of reverse transcriptase. The generated cDNA samples were used for PCR amplification in the presence of specific primers to human endoglin and L-endoglin. A single 416-bp band corresponding to the L-endoglin isoform was obtained from HMC, whereas amplification from control HUVEC resulted in the amplification of both isoforms. The 416-bp PCR product from mesangial cells was purified, cloned, and sequenced to confirm the endoglin identity. (B) Analysis by flow cytometry of endoglin present at the cell surface. HMC were incubated with a rabbit polyclonal antibody to human endoglin or with the mouse monoclonal antibody W6/32 against the human major histocompatibility antigen type I (HLA-I), followed by incubation with the corresponding secondary FITC-labeled F(abV)2 anti-Ig. Nonspecific rabbit (Control-R) or mouse (Control-M) antibodies were used as negative controls. (C) Western blot analysis. Myoblast transfectants expressing endoglin (T) or HMC (M) were lysed and total extracts were electrophoretically separated under reducing (R) or nonreducing (NR) conditions. Proteins were transferred to nitrocellulose and specific immunodetection was carried out by incubation with a polyclonal antibody to endoglin (anti-endoglin) or a preimmune antibody (Control), followed by peroxidase-conjugated goat anti-rabbit Ig. Endoglin was detected using a chemiluminescence assay. Arrowheads indicate the position of endoglin dimer (170 kDa) or endoglin monomer (80 kDa). The band with higher electrophoretic mobility than the endoglin monomer is nonspecific as it is also present in the negative control. [10, 27, 36] . Thus, the modulation of endoglin and receptor type II mRNA expression by TGF-h1 in quiescent cultured HMC was evaluated by Northern blot analysis ( Fig. 2A,B) . Two different concentrations of TGF-h1 (1 and 10 ng/ml) induced an increase in mRNA levels of endoglin and receptor type II after 24-h incubation, and scanning densitometry demonstrated quantitatively this increase. Moreover, the mRNA expression of TGF-h1 increased in the presence of TGF-h1 ligand (Fig. 2C) . These results demonstrate that TGF-h modulates the expression of the TGF-h receptor components in HMC, including endoglin, suggesting a functional role for endoglin in other TGF-h responses. In addition, the autocrine regulation by TGF-h is compatible with the maintenance of the TGF-h effects within the time period studied.
Effects of TGF-h1 on the expression of ECM proteins in HMC
Given the critical role that mesangial cells play in the glomerular and interstitial fibrosis characterized by an excess of ECM, we analyzed whether TGF-h could modulate the expression of several ECM components. As shown in Fig. 3 , treatment of HMC with TGF-h1 showed a marked increase of the mRNA levels of fibronectin, collagens I and IV. These results are in agreement with previous reports [37] and support a relevant role for TGF-h in modulating mesangial cell's functions.
ECM composition affects endoglin expression in HMC
Since TGF-h is able to affect the expression and thereby the composition of the ECM proteins, we wondered whether the presence of collagen types I or IV would in turn differentially affect the expression of endoglin in HMC. Cells were grown either in the absence or in the presence of collagen type I or IV as substrates. After 24 h in culture, the levels of endoglin mRNA were analyzed by Northern blot (Fig. 4) . Both collagen substrates significantly increased the expression of endoglin mRNA levels with respect to the uncoated control. Interestingly, endoglin transcripts were increased in the presence of collagen IV at higher levels than with collagen I. Since collagen IV is the major component of the ECM within the mesangium, these results suggest that this environment favors the expression and therefore the function of endoglin. Fig. 4 . Effects of collagen I and collagen IV substrates on endoglin mRNA expression in cultured HMC. Cells were plated on dishes previously coated or not with collagen I (COL I) and collagen IV (COL IV), as indicated. After 24 h in culture, cells were harvested, endoglin (END) and GAPDH mRNA levels were analyzed by Northern blot, and the intensity of specific bands was quantified by densitometry. Results are expressed as percent of control values and represent the mean F S.D. of three different experiments. * P < 0.05 vs. control. Mock and endoglin + fibroblast transfectants were serum-starved for 24 h prior to addition of 1 -100 ng/ml TGF-h1 in serum-free medium, as indicated. Incubation was carried out for an additional period of 24 h, cells were harvested and the collagen (COL I) mRNA expression was analyzed by Northern blot. As an internal control, RNA blots were hybridized with a probe specific for 18S RNA. A representative experiment out of three different ones is shown.
Role of endoglin in the TGF-h1-induced production of collagen
To study the role of endoglin in TGF-h-dependent responses of mesangial cells, we tried unsuccessfully to obtain stable transfectants overexpressing endoglin in this cell lineage. Therefore, we decided to use fibroblast transfectants overexpressing human endoglin that have been previously described [26] . In addition to serving as a model to study endoglin function, this cell type has the advantage of being a critical cellular component of the interstitial fibrosis occurring in several pathological conditions within the kidney. Thus, mock and endoglin + transfectants were incubated either in the absence or in the presence of TGF-h1 and 48 h later, the expression of collagen was analyzed. As expected, treatment with TGF-h1 increased the levels of collagen synthesis, as measured by proline incorporation, in both types of fibroblasts ( Fig. 5A ). However, collagen levels in untreated and TGF-h-treated endoglin + cells were significantly lower than those in control cells. This is in agreement with a previous report showing similar results with fibronectin using the same transfectants [38] , suggesting that endoglin is regulating the autocrine TGF-h pathway. Furthermore, Northern blot analyses revealed that the induction of collagen I by TGF-h1 in endoglin + fibroblasts was clearly lower than that of mock transfectants (Fig. 5B) . Taken together, these results suggest that endoglin negatively regulates the ECM levels of collagens.
Discussion
The key contribution of TGF-h1 during the progression of chronic renal disease to glomerulosclerosis and interstitial fibrosis is well established [39, 40] . TGF-h1 is a major profibrogenic factor able to induce synthesis and accumulation of several ECM components, including collagens, fibronectin, and PAI-1 [36, 39, 41, 42] . Thus, study of the TGF-h system is very important to understand the renal fibrogenic process. The auxiliary TGF-h receptor endoglin is able to modulate several TGF-h cellular responses [27 -29] and is highly expressed in the vasculature, where it plays an important role in vascular remodelling and homeostasis. This is evidenced by the fact that homozygous endoglin KO mice die at day 9.5 after gestation due to cardiovascular defects [43 -45] , and that mutations in the endoglin gene are responsible for the Hereditary Hemorrhagic Telangiectasia type 1, a disease associated with telangiectases in skin and mucosas and arteriovenous malformations in lung, liver, and brain [22, 46] . Endoglin has been shown to be upregulated in diseased human kidney with glomerulonephritis [47] , and in rat kidney with glomerular sclerosis induced by renal mass reduction [48] . In addition, expression of endoglin has been detected in human and rat mesangial cells in culture [49] . Here we have extended these findings by analyzing for the first time endoglin expression in HMC by Northern blot and RT-PCR analyses. We find that endoglin is constitutively expressed at the surface of HMC, but it can be upregulated by TGF-h1, in agreement with previous reports in human monocytic [27] and rat mesangial [49] cells. TGF-h1 not only upregulated endoglin expression, but also fibronectin, collagen type I, collagen type IV, and TGF-h itself in HMC, resembling the in vivo situation of the glomerulosclerosis. This is in agreement with previous results obtained with cell types from different lineages [7] . The importance of the TGF-h-induced modulation of these ECM components is supported by the fact that collagen I is the predominant structural component in all tissues, accounting for 90% of all collagens, whereas collagen IV is an essential component of the basal lamina [50] . In this regard, it has been reported that mesangial cells in culture behave differently with respect to their proliferative phenotype and contractile response, depending on whether they are cultured on mesangial matrix or collagen I [51] . Within the mesangium, collagen IV is the major ECM component, while collagens I and III are almost absent from the healthy glomerulus. However, upon the glomerular sclerosis associated with the ageing process, interstitial collagens I and III are induced [52] . Thus, it is tempting to speculate that endoglin is involved in the ECM synthesis by mesangial cells.
To understand the upregulation and function of the TGFh receptor component endoglin by TGF-h, we analyzed the effect of endoglin overexpression in cell transfectants. In the absence of a commercially available stable mesangial cell line, we used mouse fibroblasts stably transfected with human endoglin [26] . When the TGF-h response was analyzed in these transfectants, the collagen synthesis was found to be decreased respect to mock transfected cells, suggesting a negative role for endoglin in the TGF-hinduced ECM production. Similarly, other TGF-h responses have been found to be negatively regulated by endoglin in human monocytes [27] , human endothelial cells [29] , and rat myoblasts [28] .
Two different lines of evidence support the role of endoglin in renal pathological states: (a) endoglin has been shown to be upregulated in human kidney with glomerulonephritis [47] , and in rat kidney with glomerular sclerosis induced by renal mass reduction [48] ; and (b) certain patients with Hereditary Hemorrhagic Telangiectasia, a disease where endoglin expression is haploinsufficient, display a chronic renal disease pattern [53, 54] , and marked hepatic fibrosis [55] . In view of the results presented in this paper and previous reports [27 -29,49] , a model can be proposed for the role of endoglin in renal fibrosis (Fig. 6) . Thus, TGF-h upregulates the expression of endoglin in mesangial cells, and in turn, endoglin would counterbalance the induction of ECM components by TGF-h. The result is that endoglin would negatively affect the progression in glomerulosclerosis. It is noteworthy that TGF-h binds to proteoglycans in the matrix or near the cell surface, and such binding may also act as a negative signal to terminate the production of TGF-h after tissue repair is complete [9, 56] . In this sense, injection of the proteoglycan decorin into nephritic rats was as effective as the administration of anti-TGF-h1 in inhibiting glomerular accumulation of ECM [57] . On the other hand, the composition of the TGF-hinduced ECM might affect the equilibrium between progression or repair of glomerulosclerosis. A collagen IV, but not a collagen I, -enriched ECM would allow upregulation of endoglin facilitating the repair process. It will be interesting to determine the specific molecular mechanisms by which endoglin is modulating the outcome of renal disease.
